Live
- Hyundai Motor India Limited Announces 2024 Edition of ‘Hyundai Always Around’ Campaign
- World Quality Day: Hindustan Zinc Reaffirms Commitment to Superior Product Quality & Innovation
- Samsung TV Plus Announces the Launch of Four New FAST Channels From Viacom18 Exclusively on Samsung Smart TVs
- Arun Pandey 3.0 set to revolutionise lottery industry with Great Goa Games (GGG)
- How Organisations Can Support Mobile Workforces with Diabetes - From Prevention to Management
- Google Rolls Out Real-Time Spam Detection Feature for Pixel Users
- Marriott international and Samhi hotels announce strategic expansion, sign agreement to open three more properties in india
- Telangana Group-4 Results Declared: 8,084 Candidates Selected for 8,180 Posts
- 2024 Is Shaping Up to Be the Smallest Black Friday Ever: GoDaddy Study
- LG LAUNCHES NEW XBOOM SERIES, WITH POWERFUL SOUND WITH PORTABILITY AND STYLE
Cyient inks pact with Agappe
Cyient inks pact with Agappe
IT major Cyient has signed a manufacturing partnership with Agappe to bring indigenously developed diagnostic machine Count X to market.Mispa Count X is an indigenously designed and developed three-part haematologyanalyser, involving study and treatment of the blood, by Agappe that enables setting up of well-equipped labs in remote and rural locations across India.
Hyderabad: IT major Cyient has signed a manufacturing partnership with Agappe to bring indigenously developed diagnostic machine to market.Mispa Count X is an indigenously designed and developed three-part haematology analyser, involving study and treatment of the blood, by Agappe that enables setting up of well-equipped labs in remote and rural locations across India.
As per the agreement, Cyient will manufacture certain key components of Mispa Count X at its ISO 13485-certified, state-of-art manufacturing facilities in India.
In a regulatory filing, Cyient DLM senior V-P and CEO Rajendra Velagapudi said: "We are proud to support the vision of an Atmanirbhar Bharat (self-reliant India) in the healthcare sector.
It is a matter of immense pride that with Agappe's new haematology product, even rural India and other remote locations of the country will have access to the best of diagnostic capabilities."
